{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:44:46Z","timestamp":1793256286392,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jns.2020.117263","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T13:01:22Z","timestamp":1607518882000},"page":"117263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Guillain Barr\u00e9 Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series"],"prefix":"10.1016","volume":"420","author":[{"given":"Shitiz","family":"Sriwastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medha","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenil","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Jowkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Daimee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Bernitsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Lisak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jns.2020.117263_bb0005","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed."},{"issue":"10223","key":"10.1016\/j.jns.2020.117263_bb0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2020.117263_bb0015","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyaa033","article-title":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?","author":"Peeri","year":"2020","journal-title":"Int. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.jns.2020.117263_bb0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2020.117263_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14383","article-title":"Miller-Fisher syndrome after SARS-CoV-2 infection","author":"Reyes-Bueno","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2020.117263_bb0030","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","author":"Wu","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jns.2020.117263_bb0035","unstructured":"Baig, A.A.-O.X., et al., Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. (1948\u20137193 (Electronic))."},{"key":"10.1016\/j.jns.2020.117263_bb0040","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barre syndrome associated with SARS-CoV-2","author":"Toscano","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117263_bb0045","first-page":"1","article-title":"COVID-19 and the nervous system","author":"Berger","year":"2020","journal-title":"J. Neurovirol."},{"issue":"3","key":"10.1016\/j.jns.2020.117263_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3988\/jcn.2017.13.3.227","article-title":"Neurological complications during treatment of Middle East Respiratory Syndrome","volume":"13","author":"Kim","year":"2017","journal-title":"J. Clin. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2020.117263_bb0055","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archneur.61.11.1669","article-title":"Neuromuscular disorders in severe acute respiratory syndrome","volume":"61","author":"Tsai","year":"2004","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2020.117263_bb0060","first-page":"32","article-title":"Neuromusculoskeletal disorders following SARS: a case series","volume":"55","author":"Stainsby","year":"2011","journal-title":"J. Can. Chiropract. Assoc."},{"issue":"4","key":"10.1016\/j.jns.2020.117263_bb0065","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2020.117263_bb0070","unstructured":"Caress, J.B., et al., COVID-19-associated Guillain-Barre Syndrome: the early pandemic experience. Muscle Nerve."},{"key":"10.1016\/j.jns.2020.117263_bb0075","article-title":"New clinical manifestation of COVID-19 related Guillain-Barr\u00e8 syndrome highly responsive to intravenous immunoglobulins: two Italian cases","author":"Andrea","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2020.117263_bb0080","first-page":"1","article-title":"Early Guillain-Barr\u00e9 syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital","author":"Ottaviani","year":"2020","journal-title":"Neurol. Sci."},{"issue":"8","key":"10.1016\/j.jns.2020.117263_bb0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"Van Den Berg","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2020.117263_bb0090","article-title":"COVID-19 may induce Guillain-Barr\u00e9 syndrome","author":"Camdessanche","year":"2020","journal-title":"Rev. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2020.117263_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.17161\/rrnmf.v1i3.13816","article-title":"Neuromuscular complications in COVID-19: a review of the literature","volume":"1","author":"Pike-Lee","year":"2020","journal-title":"RRNMF Neuromuscul. J."},{"key":"10.1016\/j.jns.2020.117263_bb0100","first-page":"7(5)","article-title":"Guillain-Barr\u00e9 syndrome: The first documented COVID-19\u2013triggered autoimmune neurologic disease: more to come with myositis in the offing","author":"Dalakas","year":"2020","journal-title":"Neurology"},{"issue":"10045","key":"10.1016\/j.jns.2020.117263_bb0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-barre syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.jns.2020.117263_bb0110","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain-Barr\u00e9 syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2020.117263_bb0115","first-page":"4(8)","article-title":"HIV positive patient with GBS-like syndrome","author":"Shepherd","year":"2017","journal-title":"JMM Case Rep."},{"issue":"10027","key":"10.1016\/j.jns.2020.117263_bb0120","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.jns.2020.117263_bb0125","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain\u2013Barr\u00e9 syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117263_bb0130","first-page":"7(4)","article-title":"Guillain-Barre syndrome related to COVID-19 infection","author":"Alberti","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2020.117263_bb0135","first-page":"7(5)","article-title":"Guillain-Barr\u00e9 syndrome related to SARS-CoV-2 infection","author":"Bigaut","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2020.117263_bb0140","article-title":"Facial diplegia, a possible atypical variant of Guillain-Barr\u00e9 Syndrome as a rare neurological complication of SARS-CoV-2","author":"Caama\u00f1o","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2020.117263_bb0145","first-page":"1","article-title":"Guillain-Barr\u00e9 syndrome with facial diplegia related to SARS-CoV-2 infection","author":"Chan","year":"2020","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jns.2020.117263_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2020.04.074","article-title":"Guillain-Barre syndrome as a complication of SARS-CoV-2 infection","author":"Coen","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jns.2020.117263_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurol.2020.04.007","article-title":"Covid-19 and Guillain-Barr\u00e9 syndrome: more than a coincidence!","author":"El Otmani","year":"2020","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.jns.2020.117263_bb0160","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009619","article-title":"Miller Fisher Syndrome and polyneuritis cranialis in COVID-19","author":"Gutierrez-Ortiz","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2020.117263_bb0165","unstructured":"Kilinc, D., et al., Guillain-Barr\u00e9 syndrome after SARS-CoV-2 infection. Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2020.117263_bb0170","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3174\/ajnr.A6609","article-title":"COVID-19\u2013associated miller fisher syndrome: MRI findings","volume":"41","author":"Lantos","year":"2020","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jns.2020.117263_bb0175","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-020-09849-6","article-title":"Guillain-Barre syndrome following COVID-19: new infection, old complication?","author":"Padroni","year":"2020","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2020.117263_bb0180","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/CND.0000000000000309","article-title":"Novel coronavirus (COVID-19)-associated Guillain\u2013Barr\u00e9 Syndrome: case report","volume":"21","author":"Rana","year":"2020","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2020.117263_bb0185","first-page":"1","article-title":"Post-infectious Guillain\u2013Barr\u00e9 syndrome related to SARS-CoV-2 infection: a case report","author":"Riva","year":"2020","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2020.117263_bb0190","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.7861\/clinmed.2020-0213","article-title":"Guillain-Barr\u00e9 syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection","volume":"20","author":"Sancho-Salda\u00f1a","year":"2020","journal-title":"Clin. Med. (Lond.)"},{"key":"10.1016\/j.jns.2020.117263_bb0195","doi-asserted-by":"crossref","DOI":"10.1111\/jns.12382","article-title":"Guillain-Barre syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature","author":"Scheidl","year":"2020","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jns.2020.117263_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2020.04.062","article-title":"Guillain Barre syndrome associated with COVID-19 infection: a case report","author":"Sedaghat","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2020.117263_bb0205","series-title":"IDCases","first-page":"e00771","article-title":"Guillain-Barre Syndrome associated with SARS-CoV-2 infection","author":"Virani","year":"2020"},{"issue":"6","key":"10.1016\/j.jns.2020.117263_bb0210","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-236182","article-title":"Guillain-Barr\u00e9 syndrome following COVID-19: a newly emerging post-infectious complication","volume":"13","author":"Webb","year":"2020","journal-title":"BMJ Case Rep."},{"issue":"5","key":"10.1016\/j.jns.2020.117263_bb0215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 Syndrome Associated With SARS-CoV-2 Infection: Causality or Coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.117263_bb0220","article-title":"COVID-19 presenting with ophthalmoparesis from cranial nerve palsy","author":"Dinkin","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2020.117263_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14368","article-title":"SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: AIDP variant with favorable outcome","author":"Lascano","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2020.117263_bb0230","first-page":"1","article-title":"Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19","author":"Pfefferkorn","year":"2020","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2020.117263_bb0235","first-page":"1707","article-title":"COVID-19\u2013associated bifacial weakness with paresthesia subtype of Guillain-Barr\u00e9 syndrome","volume":"41","author":"Hutchins","year":"2020","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jns.2020.117263_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinph.2020.05.003","article-title":"Post SARS-CoV-2 Guillain-Barr\u00e9 syndrome","author":"Arnaud","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2020.117263_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/mus.26988","article-title":"SARS-CoV-2\u2013associated Guillain-Barr\u00e9 syndrome with dysautonomia","author":"Su","year":"2020","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.jns.2020.117263_bb0250","doi-asserted-by":"crossref","first-page":"156","DOI":"10.34172\/icnj.2020.18","article-title":"Guillain\u2013Barr\u00e9 syndrome as a neurological complication of COVID-19 infection: a case series and review of the literature","volume":"7","author":"Mozhdehipanah","year":"2020","journal-title":"Int. Clin. Neurosci. J."},{"issue":"7","key":"10.1016\/j.jns.2020.117263_bb0255","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-236536","article-title":"Guillain-Barr\u00e9 syndrome associated with COVID-19 infection: a case from the UK","volume":"13","author":"Tiet","year":"2020","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jns.2020.117263_bb0260","article-title":"Guillain-Barr\u00e9 Syndrome associated with the coronavirus disease 2019 (COVID-19)","author":"Ebrahimzadeh","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2020.117263_bb0265","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14388","article-title":"Guillain-Barr\u00e9 syndrome in a patient with antibodies against SARS-COV-2","author":"Helbok","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2020.117263_bb0270","first-page":"1","article-title":"Is Guillain-Barr\u00e8 syndrome triggered by SARS-CoV-2? Case report and literature review","author":"Agosti","year":"2020","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2020.117263_bb0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s42466-020-00066-0","article-title":"Guillain-Barr\u00e9 syndrome and SARS-CoV-2","volume":"2","author":"Lampe","year":"2020","journal-title":"Neurol. Res. Pract."},{"key":"10.1016\/j.jns.2020.117263_bb0280","first-page":"1","article-title":"Miller\u2013Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19)","author":"Fern\u00e1ndez-Dom\u00ednguez","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2020.117263_bb0285","article-title":"A case series of Guillain-Barr\u00e9 Syndrome following Covid-19 infection in New York","author":"Chan","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2020.117263_bb0290","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jns.12209","article-title":"International Guillain-Barr\u00e9 Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barr\u00e9 syndrome","volume":"22","author":"Jacobs","year":"2017","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"1","key":"10.1016\/j.jns.2020.117263_bb0295","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jns.2020.117263_bb0300","doi-asserted-by":"crossref","unstructured":"Moher, D., et al., The, PRISMAG (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med.. 6(7): (p. e1000097).","DOI":"10.1371\/journal.pmed.1000097"},{"issue":"7","key":"10.1016\/j.jns.2020.117263_bb0305","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jns.2020.117263_bb0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","article-title":"Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barr\u00e9 syndrome","volume":"40","author":"Jacobs","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2020.117263_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2020.06.001","article-title":"Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays","author":"La Marca","year":"2020","journal-title":"Reprod. BioMed. Online"},{"issue":"1","key":"10.1016\/j.jns.2020.117263_bb0320","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-009-0097-x","article-title":"Cerebrospinal fluid biomarkers in Guillain-Barr\u00e9 syndrome--where do we stand?","volume":"256","author":"Brettschneider","year":"2009","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2020.117263_bb0325","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/jns.12234","article-title":"Markers for Guillain-Barr\u00e9 syndrome with poor prognosis: a multi-center study","volume":"22","author":"Yamagishi","year":"2017","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"11","key":"10.1016\/j.jns.2020.117263_bb0330","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2020.117263_bb0335","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.26633\/RPSP.2020.40","article-title":"Clinical trials on drug repositioning for COVID-19 treatment","volume":"44","author":"Rosa","year":"2020","journal-title":"Rev. Panam. Salud Publica"},{"key":"10.1016\/j.jns.2020.117263_bb0340","first-page":"1","article-title":"Clinical management of adult coronavirus infection disease 2019 (COVID-19) positive in the setting of low and medium intensity of care: a short practical review","author":"Pennica","year":"2020","journal-title":"Comprehen. Clin. Med."},{"key":"10.1016\/j.jns.2020.117263_bb0345","series-title":"Dexamethasone in the Management of Covid-19","author":"Johnson","year":"2020"},{"issue":"4","key":"10.1016\/j.jns.2020.117263_bb0350","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/ebch.810","article-title":"Cochrane review: intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"6","author":"Hughes","year":"2011","journal-title":"Evid. Based Child Health"},{"key":"10.1016\/j.jns.2020.117263_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001798.pub2","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"7","author":"Raphael","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.jns.2020.117263_bb0360","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2133.2006.07390.x","article-title":"Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature","volume":"155","author":"Marie","year":"2006","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"10.1016\/j.jns.2020.117263_bb0365","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jnnp-2020-324491","article-title":"Guillain-Barr\u00e9 syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic","volume":"91","author":"Uncini","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2020.117263_bb0370","first-page":"1","article-title":"Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","author":"Abu-Rumeileh","year":"2020","journal-title":"J. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20305992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20305992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:52:43Z","timestamp":1758383563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20305992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":74,"alternative-id":["S0022510X20305992"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.117263","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guillain Barr\u00e9 Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.117263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117263"}}